{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "transcribes",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ02324",
      "entity_text" : "PD-1L",
      "entity_type" : "gene"
    },
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-0614" ],
      "Organ" : [ "uberon:UBERON:0000105" ],
      "CellType" : [ "cl:CL:0000738" ],
      "Species" : [ "taxonomy:9606" ]
    }
  },
  "verbose_text" : "Upregulation of PD-1L expression on tumor cells increases the effect of pembrolizumab.14 Combination of talimogene laherparepvec and ipilimumab has been evaluated in a phase Ib and phase II studies, both showing higher efficacy in combination than as a monotherapy of talimogene laherparepvec or ipilimumab alone.15, 16 Talimogene laherparepvec intralesional injections before pembrolizumab administration promoted the CD8 + cell infiltration into tumor.",
  "reading_complete" : "2020-08-03T11:48:36Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T11:47:50Z",
  "trigger" : "expression",
  "evidence" : [ "PD-1L expression" ],
  "pmc_id" : "6552946",
  "score" : 0
}